Szívelégtelenség: nyitott vizsgálatok itt: Törökország
12 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2/3. fázisToborozTrial-stage medicine
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Ankara, Istanbul, Izmir
- Age
- 29 nap to 17 év
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085EU 2022-501238-52-00Regiszter frissítve: 2026-10-30
3. fázisToborozTrial-stage medicine
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Adana, Afyonkarahisar, Ankara, Çorum, Eskişehir, Istanbul, Izmir, Kayseri, Kocaeli, Konya
- Age
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459Regiszter frissítve: 2026-10-29
3. fázisToborozTrial-stage medicine
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Adana, Afyonkarahisar, Ankara, Elâzığ, Erzurum, Eskişehir, Gaziantep, Istanbul, Kütahya, Malatya, Mersin, Trabzon
- Age
- 18 év and over
- People
- 6712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288EU 2023-509706-30-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Adana, Erzurum, Eskişehir, Gaziantep, Istanbul, Kütahya, Malatya, Mersin
- Age
- 18 év and over
- People
- 4200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370EU 2024-519525-38-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Adana, Ankara, Bilkent Ankara, Istanbul, Izmir
- Age
- Up to 18 év
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952EU 2024-519830-22-00Regiszter frissítve: 2026-10-27
3. fázisToborozTrial-stage medicine
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Adana, Ankara, Bilkent Ankara, Istanbul, Izmir
- Age
- 6 hónap to 17 év
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805EU 2024-519829-38-00Regiszter frissítve: 2026-10-15
3. fázisToborozResearch participation
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Adana, Ankara, Antalya, Bursa, Center, Dinar, Eskişehir, Istanbul, Izmir, Kocaeli, Kütahya, Muğla, Sivas
- Age
- 18 év to 130 év
- People
- 3850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652EU 2023-508162-15-00Regiszter frissítve: 2026-10-13
3. fázisToborozTrial-stage medicine
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Adana, Ankara, Antalya, Center, Istanbul, Izmir, Kahramanmaraş, Kütahya, Odunpazari, Yenimahalle
- Age
- 18 év and over
- People
- 6950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117EU 2026-526304-79-00Regiszter frissítve: 2026-09-28
3. fázisToborozTrial-stage medicine
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Adana, Adapazarı/Sakarya, Afyonkarahisar, Altınordu/Ordu, Ankara, Antalya, Bayraklı/İzmir, Bursa, Çanakkale/Türkiye, Canik/Samsun, Eskişehir, Istanbul, Izmir, Kayseri, Keçiören/Ankara, Kocaeli, Kütahya, Malatya, Merkez/elaziğ, Mersin, Muratpasa/ Antalya, Yakutiye / Erzurum, Yenimahalle/Ankara, Yuregir/Adana
- Age
- 18 év and over
- People
- 5610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001EU 2025-523717-29-00Regiszter frissítve: 2026-08-18
3. fázisToborozTrial-stage medicine
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Adana, Ankara, Izmir
- Age
- 2 év to 11 év
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006Regiszter frissítve: 2026-07-24
No phaseToborozResearch participation
The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients
- Where
- Ankara, Elâzığ, Erzincan, Fatih, Izmir, Kocaeli, Tekirdağ
- Age
- 18 év and over
- People
- 150 worldwide
- Run by
- Occlutech International AB
See details and how to joinNCT04405583Regiszter frissítve: 2026-06-08
3. fázisToborozTrial-stage medicine
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Adana, Ankara, Izmir
- Age
- 6 év to 11 év
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019Regiszter frissítve: 2026-05-15
Minden vizsgálat (Szívelégtelenség) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.